Open Access
THE RELATIONSHIP BETWEEN CEREBROSPINAL FLUID PRESSURE AND ATHEROGENIC INDEX OF PLASMA IN IDIOPATIC INTRACRANIAL HYPERTENSION PATIENTS
Author(s) -
Fatma Şimşek,
Recep Yevgi,
Yıldız Dağcı
Publication year - 2022
Publication title -
mnj (malang neurology journal)
Language(s) - English
Resource type - Journals
eISSN - 2442-5001
pISSN - 2407-6724
DOI - 10.21776/ub.mnj.2022.008.01.3
Subject(s) - medicine , body mass index , cerebrospinal fluid , homocysteine , overweight , endocrinology , obesity , cerebrospinal fluid pressure , triglyceride , gastroenterology , cholesterol
Background: Idiopathic intracranial hypertension (IIH) is a disease thought to be associated with obesity and rapid weight gain. There is no objective parameter with practical use in its follow-up and treatment other than optical coherence tomography. Objective: The aim of our study is to investigate the relationship between atherogenic index of plasma (AIP) and cerebrospinal fluid (CSF) pressure. Methods: Serum vitamin B12, vitamin D, homocysteine, folic acid, triglyceride (TG), high density lipoprotein cholesterol (HDL-C) levels, CSF pressure, CSF microprotein levels were recorded from the file data of patients diagnosed with IIH. AIP was calculated by dividing the TG level logarithmically by HDL-C. Height (kg) and weight (kg) data of the patients were used to calculate the body mass index (BMI). Results: File data of 64 patients were examined. 8 patients with secondary intracranial hypertension were excluded from the study. 80.36% of the patients were overweight, 16.07% were obese, 3.57% were with normal weight. There was no significant correlation between vitamin B12, vitamin D, homocysteine, HDL-C and CSF microprotein levels and CSF pressure level in patients with a diagnosis of IIH. There was a negative correlation between folic acid level and CSF pressure level, and a positive correlation between BMI, TG, AIP and CSF pressure level. Conclusion: Using folic acid supplements and drugs that reduce TG levels can contribute positively to the course of the disease.